About
Octave® Bioscience Inc. is a commercial-stage precision medicine company transforming care for Multiple Sclerosis and other neurodegenerative diseases. Its Precision Care Solution is the first industry platform to objectively measure disease activity, progression, and severity through tools such as the Octave MSDA Test — the only multivariate blood test for MS — alongside advanced MRI analytics, specialized protocols, and a clinical care program that connects patients with MS-certified nurse partners in real time. By integrating and analyzing diverse biological and contextual data layers, Octave delivers holistic, longitudinal patient insights and population-level intelligence, addressing critical unmet needs for patients, providers, pharma, and payers. Currently, the company is collaborating with leading clinics, payers, and pharmaceutical partners nationwide to advance this new paradigm of care.
Menlo Park